Business

FDA decision demolishes rapid tester’s share price

Shares in ASX-listed Lumos Diagnostics plunged by more than 60 per cent after the US regulator blocked its flagship product.

Business / Companies

Brisbane Times – Business

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:Business